Zintasa is a medication primarily used in the treatment and management of conditions related to the digestive system. It is often prescribed to individuals suffering from inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, to help reduce inflammation and alleviate symptoms. Zintasa works by releasing its active ingredient, mesalazine (also known as mesalamine), directly into the colon, where it exerts its anti-inflammatory action. This targeted approach helps in minimizing inflammation at the site, promoting healing of the intestinal lining, and providing relief from symptoms like abdominal pain, diarrhea, and rectal bleeding. It is available in various forms, including tablets, capsules, and enemas, allowing for flexible dosing and administration options tailored to the patient's specific condition and needs.